{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:10:19Z","timestamp":1793092219721,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":47,"publisher":"Springer New York","isbn-type":[{"value":"9781493933853","type":"print"},{"value":"9781493933877","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3387-7_16","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:08:16Z","timestamp":1460632096000},"page":"295-311","source":"Crossref","is-referenced-by-count":18,"title":["Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses"],"prefix":"10.1007","author":[{"given":"Michael A.","family":"Whitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad E.","family":"Mire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/tvjl.1998.0303","volume":"157","author":"GJ Letchworth","year":"1999","unstructured":"Letchworth GJ, Rodriguez LL, Del Cbarrera J (1999) Vesicular stomatitis. Vet J 157:239\u2013260","journal-title":"Vet J"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM196711092771901","volume":"277","author":"BN Fields","year":"1967","unstructured":"Fields BN, Hawkins K (1967) Human infection with the virus of vesicular stomatitis during an epizootic. N Engl J Med 277:989\u2013994","journal-title":"N Engl J Med"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","volume":"92","author":"ND Lawson","year":"1995","unstructured":"Lawson ND, Stillman EA, Whitt MA, Rose JK (1995) Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 92:4477\u20134481","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1073\/pnas.92.18.8388","volume":"92","author":"SP Whelan","year":"1995","unstructured":"Whelan SP, Ball LA, Barr JN, Wertz GT (1995) Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci U S A 92:8388\u20138392","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/JVI.71.3.1794-1801.1997","volume":"71","author":"JN Barr","year":"1997","unstructured":"Barr JN, Whelan SP, Wertz GW (1997) Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription. J Virol 71:1794\u20131801","journal-title":"J Virol"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.71.3.2127-2137.1997","volume":"71","author":"EA Stillman","year":"1997","unstructured":"Stillman EA, Whitt MA (1997) Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts. J Virol 71:2127\u20132137","journal-title":"J Virol"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1128\/JVI.72.7.5565-5572.1998","volume":"72","author":"EA Stillman","year":"1998","unstructured":"Stillman EA, Whitt MA (1998) The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation. J Virol 72:5565\u20135572","journal-title":"J Virol"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1128\/JVI.74.18.8268-8276.2000","volume":"74","author":"SP Whelan","year":"2000","unstructured":"Whelan SP, Barr JN, Wertz GW (2000) Identification of a minimal size requirement for termination of vesicular stomatitis virus mRNA: implications for the mechanism of transcription. J Virol 74:8268\u20138276","journal-title":"J Virol"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/JVI.73.1.444-452.1999","volume":"73","author":"T Li","year":"1999","unstructured":"Li T, Pattnaik AK (1999) Overlapping signals for transcription and replication at the 3\u2032 terminus of the vesicular stomatitis virus genome. J Virol 73:444\u2013452","journal-title":"J Virol"},{"key":"16_CR10","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1128\/JVI.00211-06","volume":"80","author":"SC Das","year":"2006","unstructured":"Das SC, Nayak D, Zhou Y, Pattnaik AK (2006) Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells. J Virol 80:6368\u20136377","journal-title":"J Virol"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1128\/JVI.69.3.1435-1443.1995","volume":"69","author":"BL Fredericksen","year":"1995","unstructured":"Fredericksen BL, Whitt MA (1995) Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity. J Virol 69:1435\u20131443","journal-title":"J Virol"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/viro.1996.0092","volume":"217","author":"BL Fredericksen","year":"1996","unstructured":"Fredericksen BL, Whitt MA (1996) Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion. Virology 217:49\u201357","journal-title":"Virology"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1128\/JVI.75.22.10623-10629.2001","volume":"75","author":"RN Harty","year":"2001","unstructured":"Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, Huibregtse JM, Whitt MA, Schnell MJ (2001) Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J Virol 75:10623\u201310629","journal-title":"J Virol"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1128\/JVI.74.21.9818-9827.2000","volume":"74","author":"HR Jayakar","year":"2000","unstructured":"Jayakar HR, Murti KG, Whitt MA (2000) Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol 74:9818\u20139827","journal-title":"J Virol"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1128\/JVI.76.16.8011-8018.2002","volume":"76","author":"HR Jayakar","year":"2002","unstructured":"Jayakar HR, Whitt MA (2002) Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology. J Virol 76:8011\u20138018","journal-title":"J Virol"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"12807","DOI":"10.1128\/JVI.77.23.12807-12818.2003","volume":"77","author":"E Jeetendra","year":"2003","unstructured":"Jeetendra E, Ghosh K, Odell D, Li J, Ghosh HP, Whitt MA (2003) The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J Virol 77:12807\u201312818","journal-title":"J Virol"},{"key":"16_CR17","volume":"6","author":"CE Mire","year":"2010","unstructured":"Mire CE, White JM, Whitt MA (2010) A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating. PLoS Pathog 6, e1000994","journal-title":"PLoS Pathog"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.virol.2011.04.013","volume":"416","author":"CE Mire","year":"2011","unstructured":"Mire CE, Whitt MA (2011) The protease-sensitive loop of the vesicular stomatitis virus matrix protein is involved in virus assembly and protein translation. Virology 416:16\u201325","journal-title":"Virology"},{"key":"16_CR19","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1016\/S0021-9258(19)42470-8","volume":"249","author":"JW Huang","year":"1974","unstructured":"Huang JW, Davey MW, Hejna CJ, Von Muenchhausen W, Sulkowski E, Carter WA (1974) Selective binding of human interferon to albumin immoblized on agarose. J Biol Chem 249:4665\u20134667","journal-title":"J Biol Chem"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/0042-6822(77)90261-6","volume":"76","author":"RA Weiss","year":"1977","unstructured":"Weiss RA, Boettiger D, Murphy HM (1977) Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus. Virology 76:808\u2013825","journal-title":"Virology"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(77)90068-X","volume":"11","author":"ON Witte","year":"1977","unstructured":"Witte ON, Baltimore D (1977) Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus. Cell 11:505\u2013511","journal-title":"Cell"},{"key":"16_CR22","first-page":"103","volume":"16","author":"J Zavada","year":"1972","unstructured":"Zavada J, Rosenbergova M (1972) Phenotypic mixing of vesicular stomatitis virus with fowl plague virus. Acta Virol 16:103\u2013114","journal-title":"Acta Virol"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virusres.2004.08.009","volume":"106","author":"HR Jayakar","year":"2004","unstructured":"Jayakar HR, Jeetendra E, Whitt MA (2004) Rhabdovirus assembly and budding. Virus Res 106:117\u2013132","journal-title":"Virus Res"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(00)80350-5","volume":"90","author":"MJ Schnell","year":"1997","unstructured":"Schnell MJ, Johnson JE, Buonocore L, Rose JK (1997) Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90:849\u2013857","journal-title":"Cell"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1073\/pnas.94.26.14764","volume":"94","author":"A Takada","year":"1997","unstructured":"Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y (1997) A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94:14764\u201314769","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1128\/JVI.74.5.2239-2246.2000","volume":"74","author":"CS Robison","year":"2000","unstructured":"Robison CS, Whitt MA (2000) The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. J Virol 74:2239\u20132246","journal-title":"J Virol"},{"key":"16_CR27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","volume":"11","author":"SM Jones","year":"2005","unstructured":"Jones SM, Feldmann H, Stroher U, Geisbert JB, Fernando L et al (2005) Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11:786\u2013790","journal-title":"Nat Med"},{"key":"16_CR28","first-page":"26","volume":"101","author":"MK Lo","year":"2013","unstructured":"Lo MK, Bird BH, Chattopadhyay A, Drew CP, Martin BE et al (2013) Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters. Antiviral Res 101:26\u201329","journal-title":"Antiviral Res"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nature14428","volume":"520","author":"CE Mire","year":"2015","unstructured":"Mire CE, Matassov D, Geisbert JB, Latham TE, Agans KN et al (2015) Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus. Nature 520:688\u2013691","journal-title":"Nature"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1743-422X-10-353","volume":"10","author":"CE Mire","year":"2013","unstructured":"Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW (2013) Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virol J 10:353","journal-title":"Virol J"},{"issue":"Suppl 3","key":"16_CR31","doi-asserted-by":"crossref","first-page":"S1066","DOI":"10.1093\/infdis\/jir348","volume":"204","author":"A Marzi","year":"2011","unstructured":"Marzi A, Ebihara H, Callison J, Groseth A, Williams KJ, Geisbert TW, Feldmann H (2011) Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J Infect Dis 204(Suppl 3):S1066\u2013S1074","journal-title":"J Infect Dis"},{"key":"16_CR32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003736","volume":"9","author":"D Safronetz","year":"2015","unstructured":"Safronetz D, Mire C, Rosenke K, Feldmann F, Haddock E, Geisbert T, Feldmann H (2015) A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. PLoS Negl Trop Dis 9, e0003736","journal-title":"PLoS Negl Trop Dis"},{"key":"16_CR33","doi-asserted-by":"crossref","unstructured":"Matassov D, Marzi A, Latham T, Xu R, Ota-Setlik A et al (2015) Vaccination with a highly attenuated recombinant vesicular stomatitis virus vector protects against challenge with a lethal dose of ebola virus. J Infect Dis pii: jiv316. [Epub ahead of print] PubMed PMID: 26109675.","DOI":"10.1093\/infdis\/jiv316"},{"key":"16_CR34","doi-asserted-by":"crossref","unstructured":"Mire CE, Geisbert JB, Versteeg KM, Mamaeva N, Agans KN, Geisbert TW, Connor JH (2015) A single-vector, single-injection trivalent filovirus vaccine: proof of concept study in outbred guinea pigs. J Infect Dis pii: jiv126. [Epub ahead of print] PubMed PMID: 25957964.","DOI":"10.1093\/infdis\/jiv126"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1099\/0022-1317-5-2-251","volume":"5","author":"L Kaariainen","year":"1969","unstructured":"Kaariainen L, Gomatos PJ (1969) A kinetic analysis of the synthesis in BHK 21 cells of RNAs specific for Semliki Forest virus. J Gen Virol 5:251\u2013265","journal-title":"J Gen Virol"},{"key":"16_CR36","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1128\/JVI.01181-07","volume":"81","author":"M Porotto","year":"2007","unstructured":"Porotto M, Carta P, Deng Y, Kellogg GE, Whitt M, Lu M, Mungall BA, Moscona A (2007) Molecular determinants of antiviral potency of paramyxovirus entry inhibitors. J Virol 81:10567\u201310574","journal-title":"J Virol"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","volume":"169","author":"MA Whitt","year":"2010","unstructured":"Whitt MA (2010) Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J Virol Methods 169:365\u2013374","journal-title":"J Virol Methods"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/JVI.69.5.2946-2953.1995","volume":"69","author":"EA Stillman","year":"1995","unstructured":"Stillman EA, Rose JK, Whitt MA (1995) Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins. J Virol 69:2946\u20132953","journal-title":"J Virol"},{"key":"16_CR39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JVI.76.1.406-410.2002","volume":"76","author":"G Neumann","year":"2002","unstructured":"Neumann G, Feldmann H, Watanabe S, Lukashevich I, Kawaoka Y (2002) Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol 76:406\u2013410","journal-title":"J Virol"},{"key":"16_CR40","doi-asserted-by":"crossref","first-page":"12300","DOI":"10.1128\/JVI.76.23.12300-12311.2002","volume":"76","author":"E Jeetendra","year":"2002","unstructured":"Jeetendra E, Robison CS, Albritton LM, Whitt MA (2002) The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J Virol 76:12300\u201312311","journal-title":"J Virol"},{"key":"16_CR41","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1073\/pnas.83.21.8122","volume":"83","author":"TR Fuerst","year":"1986","unstructured":"Fuerst TR, Niles EG, Studier FW, Moss B (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A 83:8122\u20138126","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/viro.1995.1332","volume":"210","author":"LS Wyatt","year":"1995","unstructured":"Wyatt LS, Moss B, Rozenblatt S (1995) Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210:202\u2013205","journal-title":"Virology"},{"key":"16_CR43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","volume":"73","author":"UJ Buchholz","year":"1999","unstructured":"Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251\u2013259","journal-title":"J Virol"},{"key":"16_CR44","first-page":"513","volume":"3","author":"RN Harty","year":"2001","unstructured":"Harty RN, Brown ME, Hayes FP, Wright NT, Schnell MJ (2001) Vaccinia virus-free recovery of vesicular stomatitis virus. J Mol Microbiol Biotechnol 3:513\u2013517","journal-title":"J Mol Microbiol Biotechnol"},{"key":"16_CR45","first-page":"520","volume":"10","author":"JK Rose","year":"1991","unstructured":"Rose JK, Buonocore L, Whitt MA (1991) A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques 10:520\u2013525","journal-title":"Biotechniques"},{"key":"16_CR46","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","volume":"78","author":"M Garbutt","year":"2004","unstructured":"Garbutt M, Liebscher R, Wahl-Jensen V, Jones S et al (2004) Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol 78:5458\u20135465","journal-title":"J Virol"},{"key":"16_CR47","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/clpt.2008.23","volume":"83","author":"R Roberts","year":"2008","unstructured":"Roberts R, McCune SK (2008) Animal studies in the development of medical countermeasures. Clin Pharmacol Ther 83:918\u2013920","journal-title":"Clin Pharmacol Ther"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3387-7_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T20:39:56Z","timestamp":1655498396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3387-7_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933853","9781493933877"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3387-7_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}